Mouse Anti-DNMT1 Recombinant Antibody (CBT4540) (V2LY-0625-LY66)






Basic Information
Application | Note |
WB | 1:500-1:2,000 |
IHC-P | 1:200-1:1,000 |
ELISA | 1:10,000 |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306).
Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306).
Promotes tumor growth (PubMed:24623306).
Chromatin organization Source: UniProtKB-KW
DNA methylation Source: ProtInc
DNA methylation involved in embryo development Source: Ensembl
Gene silencing Source: Ensembl
Maintenance of DNA methylation Source: UniProtKB
Negative regulation of gene expression Source: BHF-UCL
Negative regulation of histone H3-K9 methylation Source: UniProtKB
Negative regulation of transcription by RNA polymerase II Source: ProtInc
Negative regulation of vascular associated smooth muscle cell apoptotic process Source: BHF-UCL
Negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching Source: BHF-UCL
Positive regulation of DNA methylation-dependent heterochromatin assembly Source: UniProtKB
Positive regulation of gene expression Source: UniProtKB
Positive regulation of histone H3-K4 methylation Source: UniProtKB
Positive regulation of vascular associated smooth muscle cell proliferation Source: BHF-UCL
Ras protein signal transduction Source: UniProtKB
A neurodegenerative disorder characterized by adult onset of progressive peripheral sensory loss associated with progressive hearing impairment and early-onset dementia.
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant (ADCADN):
An autosomal dominant neurologic disorder characterized by adult onset of progressive cerebellar ataxia, narcolepsy, cataplexy, sensorineural deafness, and dementia. More variable features include optic atrophy, sensory neuropathy, psychosis, and depression.
Acetylation on multiple lysines, mainly by KAT2B/PCAF, regulates cell cycle G2/M transition. Deacetylation of Lys-1349 and Lys-1415 by SIRT1 increases methyltransferase activity.
Phosphorylation of Ser-154 by CDKs is important for enzymatic activity and protein stability. Phosphorylation of Ser-143 by AKT1 prevents methylation by SETD7 therebye increasing DNMT1 stability.
Methylation at Lys-142 by SETD7 promotes DNMT1 proteasomal degradation.
Ubiquitinated by UHRF1; interaction with USP7 counteracts ubiquitination by UHRF1 by promoting deubiquitination and preventing degradation by the proteasome.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Mouse Anti-DNMT1 Recombinant Antibody (D1398) (CAT#: CBMAB-D1399-YC)
Rabbit Anti-DNMT1 Recombinant Antibody (10E20) (CAT#: CBMAB-D1403-YC)
Mouse Anti-DNMT1 Recombinant Antibody (D1401) (CAT#: CBMAB-D1401-YC)
Mouse Anti-DNMT1 Recombinant Antibody (CBT4483) (CAT#: V2LY-0625-LY513)
Mouse Anti-DNMT1 Recombinant Antibody (10F697) (CAT#: CBMAB-D1393-YC)
Mouse Anti-DNMT1 Recombinant Antibody (CBT3607) (CAT#: V2LY-0625-LY514)
Rabbit Anti-DNMT1 Recombinant Antibody (D1405) (CAT#: CBMAB-D1405-YC)
Mouse Anti-DNMT1 Recombinant Antibody (D1397) (CAT#: CBMAB-D1397-YC)
Mouse Anti-DNMT1 Recombinant Antibody (D1400) (CAT#: CBMAB-D1400-YC)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
